FdaNdcDirectoryPulse / compare
BRYTLY vs Aphonie Hair Regrowth Treatment for Men: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and Aphonie Hair Regrowth Treatment for Men (2026-10-08) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to Aphonie Hair Regrowth Treatment for Men?
| Field | BRYTLY | Aphonie Hair Regrowth Treatment for Men |
|---|---|---|
| Product | BRYTLY | Aphonie Hair Regrowth Treatment for Men |
| Generic name | Apraclonidine Hydrochloride | MINOXIDIL |
| NDC | 0065-8596 | 87722-413 |
| Labeler | Alcon Laboratories, Inc. | Guangdong Jiaoyu Biotechnology Co., Ltd |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | OTC MONOGRAPH DRUG |
| Application number | NDA220341 | M032 |
| Dosage form | SOLUTION/ DROPS | SOLUTION |
| Route | OPHTHALMIC | TOPICAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | MINOXIDIL 5 g/100mL |
| Marketing start | 2026-10-16 | 2026-10-08 |
| Package configurations | 3 | 1 |
| Launch Signal Score | 45/100 | 15/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · Aphonie Hair Regrowth Treatment for Men
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.